Kristine Peterson is Director of ImmunoGen, Inc.. Currently has a direct ownership of 0 shares of IMGN, which is worth approximately $0. The most recent transaction as insider was on Nov 30, 2023, when has been sold 20,000 shares (Common Stock) at a price of $28.9 per share, resulting in proceeds of $578,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
n/a 12M change
Total Value Held $0

Kristine Peterson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 30 2023
SELL
Open market or private sale
$578,000 $28.9 p/Share
20,000 Reduced 100.0%
0 Common Stock
Nov 30 2023
BUY
Exercise of conversion of derivative security
$231,800 $11.59 p/Share
20,000 Added 50.0%
20,000 Common Stock
Sep 13 2023
SELL
Exercise of conversion of derivative security
$160,799 $16.08 p/Share
10,000 Reduced 100.0%
0 Common Stock
Sep 13 2023
BUY
Exercise of conversion of derivative security
$147,000 $14.7 p/Share
10,000 Added 50.0%
10,000 Common Stock

Also insider at

IMCR
Immunocore Holdings plc Healthcare
ENTA
ENANTA PHARMACEUTICALS INC Healthcare
AMRN
AMARIN CORP PLCUK Healthcare
PRTK
Paratek Pharmaceuticals, Inc. Healthcare
AVBP
ArriVent Biopharma, Inc.
KP

Kristine Peterson

Director
Waltham, MA

Track Institutional and Insider Activities on IMGN

Follow ImmunoGen, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMGN shares.

Notify only if

Insider Trading

Get notified when an Immuno Gen, Inc. insider buys or sells IMGN shares.

Notify only if

News

Receive news related to ImmunoGen, Inc.

Track Activities on IMGN